Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>

Infections caused by carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) remain a clinical challenge due to limited treatment options. Recently, cefiderocol, a novel siderophore cephalosporin, and sulbactam-durlobactam, a bactericidal β-lactam–β-lactamase inhibitor combination, have been appr...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Arta Karruli, Antonella Migliaccio, Spyros Pournaras, Emanuele Durante-Mangoni, Raffaele Zarrilli
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2023-12-01
Cyfres:	Antibiotics
Pynciau:	carbapenem-resistant <i>Acinetobacter baumannii</i> cefiderocol sulbactam-durlobactam antimicrobial susceptibility mechanisms of resistance antimicrobial therapy
Mynediad Ar-lein:	https://www.mdpi.com/2079-6382/12/12/1729
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!